Literature DB >> 9016427

Predictors of mortality after acute hip fracture.

M D Nettleman1, J Alsip, M Schrader, M Schulte.   

Abstract

To identify determinants of mortality after hip fracture, we performed a multicenter, retrospective study of 390 Medicare beneficiaries. Independent predictors of 30-day mortality included a history of congestive heart failure (odds ratio [OR] 32; 95% confidence interval [CI] 5, 192), angina (OR 26; 95% CI 4, 184), or chronic pulmonary disease (OR 11; 95% CI 2, 62). Postoperative use of aspirin was associated with a reduced risk of mortality (OR 0.24; 95% CI 0.08, 0.70). Cardiovascular events were the presumed cause of 63% of in-hospital deaths. Aspirin may have significant potential to reduce mortality in this population and deserves further study.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9016427     DOI: 10.1007/bf02598997

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  20 in total

1.  The health care quality improvement initiative. A new approach to quality assurance in Medicare.

Authors:  S F Jencks; G R Wilensky
Journal:  JAMA       Date:  1992-08-19       Impact factor: 56.272

2.  Determinants of recovery 12 months after hip fracture: the importance of psychosocial factors.

Authors:  J M Mossey; E Mutran; K Knott; R Craik
Journal:  Am J Public Health       Date:  1989-03       Impact factor: 9.308

Review 3.  Prevention of venous thromboembolism.

Authors:  G P Clagett; F A Anderson; J Heit; M N Levine; H B Wheeler
Journal:  Chest       Date:  1995-10       Impact factor: 9.410

4.  Aspirin for prevention of myocardial infarction.

Authors: 
Journal:  Med Lett Drugs Ther       Date:  1995-02-17       Impact factor: 1.909

5.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

6.  Changing patterns of hip fracture care before and after implementation of the prospective payment system.

Authors:  J F Fitzgerald; L F Fagan; W M Tierney; R S Dittus
Journal:  JAMA       Date:  1987-07-10       Impact factor: 56.272

7.  Collaborative overview of randomised trials of antiplatelet therapy--III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-22

8.  Hip fractures in the elderly: a world-wide projection.

Authors:  C Cooper; G Campion; L J Melton
Journal:  Osteoporos Int       Date:  1992-11       Impact factor: 4.507

9.  Physician practices in the prevention of venous thromboembolism.

Authors:  F A Anderson; H B Wheeler; R J Goldberg; D W Hosmer; A Forcier; N A Patwardhan
Journal:  Ann Intern Med       Date:  1991-10-15       Impact factor: 25.391

10.  Hip fractures among the elderly: factors associated with in-hospital mortality.

Authors:  A H Myers; E G Robinson; M L Van Natta; J D Michelson; K Collins; S P Baker
Journal:  Am J Epidemiol       Date:  1991-11-15       Impact factor: 4.897

View more
  19 in total

1.  Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study.

Authors:  J J W Roche; R T Wenn; O Sahota; C G Moran
Journal:  BMJ       Date:  2005-11-18

Review 2.  Hip fracture prevention: cost-effective strategies.

Authors:  P Vestergaard; L Rejnmark; L Mosekilde
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

3.  Preoperative thyroid dysfunction predicts 30-day postoperative complications in elderly patients with hip fracture.

Authors:  Xi Wern Ling; Tet Sen Howe; Joyce Suang Bee Koh; Merng Koon Wong; Alvin Choong Meng Ng
Journal:  Geriatr Orthop Surg Rehabil       Date:  2013-06

4.  Risk factors for mortality in geriatric hip fractures: a compressional study of different surgical procedures in 785 consecutive patients.

Authors:  Ersin Ercin; M Gokhan Bilgili; Cihangir Sari; S Hakan Basaran; Bulent Tanriverdi; Erdem Edipoglu; K Mumtaz Celen; Halil Cetingok; Cemal Kural
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-08-31

5.  Quality of life, morbidity, and mortality after low trauma hip fracture in men.

Authors:  I Pande; D L Scott; T W O'Neill; C Pritchard; A D Woolf; M J Davis
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

6.  Functional outcomes and mortality vary among different types of hip fractures: a function of patient characteristics.

Authors:  Roger Cornwall; Marvin S Gilbert; Kenneth J Koval; Elton Strauss; Albert L Siu
Journal:  Clin Orthop Relat Res       Date:  2004-08       Impact factor: 4.176

7.  Chronic obstructive pulmonary disease and mortality following hip fracture: a population-based cohort study.

Authors:  Cynthia de Luise; Michael Brimacombe; Lars Pedersen; Henrik Toft Sørensen
Journal:  Eur J Epidemiol       Date:  2007-11-24       Impact factor: 8.082

8.  Hip fractures and heart failure: findings from the Cardiovascular Health Study.

Authors:  Laura Carbone; Petra Buzková; Howard A Fink; Jennifer S Lee; Zhao Chen; Ali Ahmed; Susmita Parashar; John R Robbins
Journal:  Eur Heart J       Date:  2009-11-04       Impact factor: 29.983

9.  Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications.

Authors:  P Vestergaard; L Rejnmark; L Mosekilde
Journal:  Osteoporos Int       Date:  2007-06-14       Impact factor: 4.507

10.  Quality of care and 30 day mortality among patients with hip fractures: a nationwide cohort study.

Authors:  Katrine A Nielsen; Niels C Jensen; Claus M Jensen; Marianne Thomsen; Lars Pedersen; Søren P Johnsen; Annette Ingeman; Paul D Bartels; Reimar W Thomsen
Journal:  BMC Health Serv Res       Date:  2009-10-12       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.